4//SEC Filing
Cyclacel Pharmaceuticals, Inc. 4
Accession 0001571049-15-009883
$BGMSCIK 0001130166operating
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:22 PM ET
Size
5.8 KB
Accession
0001571049-15-009883
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Option
2015-12-07+437,569→ 437,569 totalExercise: $0.59Exp: 2025-12-07→ Common Stock (437,569 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted to Mr. Rombotis under the Issuer's 2015 Equity Incentive Plan as part of the Issuer's annual compensation review to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001130166
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:22 PM ET
- Size
- 5.8 KB